The importance of plasma cholesterol reduction as a risk modifer for cardiovascular disease had been clearly demonstrated in large clinical trials using the statin class of lipid-lowering agents. Studies have revealed that lowering plasma cholesterol levels not only reduced cardiovascular disease morbidity, but also reduced stroke rates
Performer
Panel of speakers: Dr. Norman Swan, Dr. David Sullivan, Dr. Greg Fulcher and Dr. David Malikoff
Audience
For people in rural areas
Notes
No rating given
DVD. Region unspecified
Available to Deakin University staff and students only